Search Results for: Roche
Trials & Approvals Roche
Roche’s Non-Hodgkin Lymphoma Drug Could See Accelerated Approval By December
2022-07-07
Trials & Approvals FDA
Eisai and Biogen’s New Alzheimer’s Drug to Receive FDA Decision by January
2022-07-06
Funding Blueprint Medicines
Blueprint Medicines Gathers Up To $1.25 Billion in Loans and Investments for Research and Development
2022-07-01
Trials & Approvals Multiple Sclerosis
FDA Halts Sanofi’s $3.7B Multiple Sclerosis Investment
2022-07-01
PRNewswire
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials
2022-06-22
Funding Series A Funding
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Licensing CDMO
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Trials & Approvals Follicular Lymphoma
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
M&A Bristol Myers Squibb
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
Licensing Astellas Pharma
Astellas’ $20.5M Deal With GO Therapeutics to Develop Immuno-Oncology Therapeutics
2022-06-02
Trials & Approvals Spinal Muscular Atrophy
First Oral SMA Drug by Roche Now Available to Newborns
2022-06-01
R&D Obesity
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
Deals Cancer Immunotherapy
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Trials & Approvals Merck
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Regulatory Alzheimer's Drug
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
1 … 4 5 6 7 8 … 20
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top